BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang G, Tang B. Current advances in the nano-delivery of celastrol for treating inflammation-associated diseases. J Mater Chem B 2020;8:10954-65. [PMID: 33174584 DOI: 10.1039/d0tb01939a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Chen Q, Yan L, Ren Y, Fan J, Zhang X, Zhu S. Phytosomal tripterine with selenium modification attenuates the cytotoxicity and restrains the inflammatory evolution via inhibiting NLRP3 inflammasome activation and pyroptosis. International Immunopharmacology 2022;108:108871. [DOI: 10.1016/j.intimp.2022.108871] [Reference Citation Analysis]
2 Wagh PR, Desai P, Prabhu S, Wang J. Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications. Front Pharmacol 2021;12:673209. [PMID: 34177584 DOI: 10.3389/fphar.2021.673209] [Reference Citation Analysis]
3 Liu D, Zhang Q, Luo P, Gu L, Shen S, Tang H, Zhang Y, Lyu M, Shi Q, Yang C, Wang J. Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets. Aging Dis 2022;13:815-36. [PMID: 35656110 DOI: 10.14336/AD.2021.1115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bai S, Shao X, Tao Y, Wang S, Han H, Li Q. Superoxide dismutase-embedded metal–organic frameworks via biomimetic mineralization for the treatment of inflammatory bowel disease. J Mater Chem B. [DOI: 10.1039/d2tb00896c] [Reference Citation Analysis]